PCGEM1 and ovarian carcinoma: Alternatively, the ability of miR-129-5p in the inhibition of ovarian cancer cell proliferation and survival was defined previously, which highlighted the role of the PCGEM1 and miR-129-5p as the treatment options in epithelial ovarian cancer [119].